Researcher at HEPII (Health Economics, Policy and Innovation Institute) @veda_econmuni. Former director @IZA_MZSR (Institute for healthcare analyses, MoH)
Drug prices declined substantially after patent expiration across 8 high-income countries, from 30% to 80% during the 8 years after patent expiration. https://t.co/Fd2xD0bYsT @KNVokinger